B Group, Inc. Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, B Group, Inc. disclosed 18 stock positions valued at approximately $176.19M as of quarter-end June 30, 2026. The largest holdings include ADMA BIOLOGICS INC, PALISADE BIO INC, and NRX PHARMACEUTICALS INC.

Report Period
June 30, 2026
No. of Stocks
18
Portfolio Value
$176.19M
Holdings by Sector
B Group, Inc. Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
ADMA BIOLOGICS INCADMAHealthcare15.50%3,262,542+55,000+1.71%$27,307,477
PALISADE BIO INCPALIOther13.54%11,414,285--$23,855,856
NRX PHARMACEUTICALS INCNRXPHealthcare9.50%4,091,767+1,091,767+36.39%$16,735,327
FAETH THERAPEUTICS INCFTHOther8.66%610,169+610,169+100.00%$15,254,225
TAYSHA GENE THERAPIES INCTSHAHealthcare6.96%1,800,556--$12,261,786
PRAXIS PRECISION MEDICINES IPRAXHealthcare6.32%33,237--$11,127,415
CELLECTIS S ACLLSHealthcare5.59%3,281,501--$9,844,503
ZAI LAB LTDZLABHealthcare4.86%450,646--$8,562,274
STRUCTURE THERAPEUTICS INCGPCRHealthcare4.26%140,000+12,500+9.80%$7,513,800
ORUKA THERAPEUTICS INCORKAOther4.05%75,000--$7,137,750
IOVANCE BIOTHERAPEUTICS INCIOVAHealthcare3.54%1,500,000--$6,240,000
SPYRE THERAPEUTICS INCSYREHealthcare3.53%70,000-30,000-30.00%$6,214,600
AURA BIOSCIENCES INCAURAHealthcare3.08%764,243+166,667+27.89%$5,426,125
ASSEMBLY BIOSCIENCES INCASMBHealthcare2.74%175,706--$4,828,401
BRIGHT MINDS BIOSCIENCES INCDRUGOther2.69%67,500--$4,738,500
ULTRAGENYX PHARMACEUTICAL INRAREHealthcare2.56%135,000--$4,507,650
SIGHT SCIENCES INCSGHTHealthcare2.08%970,000--$3,656,900
FOGHORN THERAPEUTICS INCFHTXHealthcare0.55%200,000+98,000+96.08%$976,000
Showing 18 of 18 holdings in the latest reporting period.